Medico Remedies Limited (MEDICO) - Net Assets

Latest as of March 2026: Rs754.74 Million INR ≈ $8.16 Million USD

Based on the latest financial reports, Medico Remedies Limited (MEDICO) has net assets worth Rs754.74 Million INR (≈ $8.16 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs1.53 Billion ≈ $16.59 Million USD) and total liabilities (Rs779.29 Million ≈ $8.43 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Medico Remedies Limited tangible equity quality to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Rs754.74 Million
% of Total Assets	49.2%
Annual Growth Rate	23.12%
5-Year Change	102.24%
10-Year Change	361.0%
Growth Volatility	21.97

Medico Remedies Limited - Net Assets Trend (2013–2026)

This chart illustrates how Medico Remedies Limited's net assets have evolved over time, based on quarterly financial data. See operational self-sufficiency of Medico Remedies Limited to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Medico Remedies Limited (2013–2026)

The table below shows the annual net assets of Medico Remedies Limited from 2013 to 2026. For live valuation and market cap data, see Medico Remedies Limited (MEDICO) total market value.

Year	Net Assets	Change
2026-03-31	Rs754.74 Million ≈ $8.16 Million	+20.82%
2025-03-31	Rs624.69 Million ≈ $6.76 Million	+19.28%
2024-03-31	Rs523.71 Million ≈ $5.66 Million	+19.45%
2023-03-31	Rs438.43 Million ≈ $4.74 Million	+17.48%
2022-03-31	Rs373.20 Million ≈ $4.04 Million	+14.98%
2021-03-31	Rs324.58 Million ≈ $3.51 Million	+8.68%
2020-03-31	Rs298.66 Million ≈ $3.23 Million	+5.77%
2019-03-31	Rs282.36 Million ≈ $3.05 Million	+5.89%
2018-03-31	Rs266.66 Million ≈ $2.88 Million	+62.88%
2017-03-31	Rs163.72 Million ≈ $1.77 Million	+11.04%
2016-03-31	Rs147.44 Million ≈ $1.59 Million	+8.30%
2015-03-31	Rs136.14 Million ≈ $1.47 Million	+58.82%
2014-03-31	Rs85.72 Million ≈ $927.00K	+69.56%
2013-03-31	Rs50.55 Million ≈ $546.71K	--

Equity Component Analysis

This analysis shows how different components contribute to Medico Remedies Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 100.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (March 2026)

Component	Amount	Percentage
Common Stock	Rs165.97 Million	21.99%
Other Components	Rs588.78 Million	78.01%
Total Equity	Rs754.75 Million	100.00%

Medico Remedies Limited Competitors by Market Cap

The table below lists competitors of Medico Remedies Limited ranked by their market capitalization.

Company	Market Cap
Blackboxstocks Inc NASDAQ:BLBX	$38.66 Million
Sepeda Bersama Indonesia Tbk PT JK:BIKE	$38.67 Million
Hojeon Ltd KO:111110	$38.70 Million
Toplus Global Co Ltd TWO:3522	$38.70 Million
INFOMARK Co. Ltd KQ:175140	$38.65 Million
Anteotech Ltd AU:ADO	$38.65 Million
CESSATECH A/S DK -20 F:8GN	$38.64 Million
First Graphene Ltd AU:FGR	$38.63 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Medico Remedies Limited's equity between the two most recent reporting periods.

Equity Growth Insights

From 2025 to 2026, total equity changed from 624,689,000 to 754,745,000, a change of 130,056,000 (20.8%).
Net income of 131,151,999 contributed positively to equity growth.
Other comprehensive income decreased equity by 2,402,000.

Equity Change Factors (2025 to 2026)

Factor	Impact	Contribution
Net Income	Rs131.15 Million	+17.38%
Other Comprehensive Income	Rs-2.40 Million	-0.32%
Other Changes	Rs1.31 Million	+0.17%
Total Change	Rs-	20.82%

Book Value vs Market Value Analysis

This analysis compares Medico Remedies Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 4.74x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 70.70x to 4.74x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2013-03-31	Rs0.61	Rs43.07	x
2014-03-31	Rs1.03	Rs43.07	x
2015-03-31	Rs1.64	Rs43.07	x
2016-03-31	Rs1.78	Rs43.07	x
2017-03-31	Rs1.97	Rs43.07	x
2018-03-31	Rs3.98	Rs43.07	x
2019-03-31	Rs3.40	Rs43.07	x
2020-03-31	Rs3.60	Rs43.07	x
2021-03-31	Rs3.91	Rs43.07	x
2022-03-31	Rs4.49	Rs43.07	x
2023-03-31	Rs5.28	Rs43.07	x
2024-03-31	Rs6.31	Rs43.07	x
2025-03-31	Rs7.55	Rs43.07	x
2026-03-31	Rs9.09	Rs43.07	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Medico Remedies Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 17.38%
The company demonstrates strong efficiency in generating profits from shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 6.35%
• Asset Turnover: 1.35x
• Equity Multiplier: 2.03x
Recent ROE (17.38%) is above the historical average (10.11%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2013	8.46%	1.27%	1.84x	3.63x	Rs-780.30K
2014	7.34%	1.40%	1.44x	3.64x	Rs-2.28 Million
2015	5.82%	1.55%	1.43x	2.63x	Rs-5.69 Million
2016	7.66%	1.69%	1.46x	3.09x	Rs-3.44 Million
2017	9.94%	2.99%	1.13x	2.95x	Rs-90.80K
2018	4.58%	2.00%	1.03x	2.23x	Rs-14.46 Million
2019	5.56%	1.61%	1.28x	2.70x	Rs-12.53 Million
2020	5.46%	1.84%	1.18x	2.52x	Rs-13.56 Million
2021	7.98%	2.12%	1.62x	2.33x	Rs-6.56 Million
2022	12.89%	3.98%	1.59x	2.04x	Rs10.80 Million
2023	16.52%	5.16%	1.61x	1.99x	Rs28.57 Million
2024	15.83%	5.72%	1.51x	1.84x	Rs30.54 Million
2025	16.16%	6.69%	1.26x	1.92x	Rs38.46 Million
2026	17.38%	6.35%	1.35x	2.03x	Rs55.68 Million

Industry Comparison

This section compares Medico Remedies Limited's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

Industry: Drug Manufacturers - Specialty & Generic
Average net assets among peers: $41,118,163,484
Average return on equity (ROE) among peers: 13.86%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Medico Remedies Limited (MEDICO)	Rs754.74 Million	8.46%	1.03x	$38.65 Million
Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS)	$366.97 Million	3.51%	2.41x	$25.11 Million
Aarti Drugs Limited (AARTIDRUGS)	$1.23 Billion	12.93%	2.27x	$365.36 Million
Aarti Pharmalabs Limited (AARTIPHARM)	$2.31 Million	-8.08%	0.08x	$645.54 Million
Abbott India Limited (ABBOTINDIA)	$2.31 Billion	29.62%	0.43x	$6.01 Billion
Ajanta Pharma Limited (AJANTPHARM)	$32.64 Billion	21.83%	0.24x	$4.15 Billion
Akums Drugs and Pharmaceutical (AKUMS)	$7.23 Billion	13.11%	3.52x	$996.26 Million
Alkem Laboratories Limited (ALKEM)	$75.58 Billion	20.97%	0.52x	$6.95 Billion
Amrutanjan Health Care Limited (AMRUTANJAN)	$1.09 Billion	18.92%	0.29x	$170.62 Million
Alembic Pharmaceuticals Limited (APLLTD)	$22.20 Billion	18.58%	0.77x	$1.59 Billion
Aurobindo Pharma Limited (AUROPHARMA)	$268.52 Billion	7.18%	0.49x	$8.98 Billion

About Medico Remedies Limited

NSE:MEDICO India Drug Manufacturers - Specialty & Generic

Market Cap

$38.65 Million

Rs3.57 Billion INR

Market Cap Rank

#22894 Global

#1273 in India

Share Price

Rs43.07

Change (1 day)

+0.33%

52-Week Range

Rs32.76 - Rs54.24

All Time High

Rs96.70